Expertise in
6
conditions

Christian M. Kurbacher

Medizinisches Zentrum Bonn Friedensplatz
Bonn, NW, DE 
Expertise in
6
conditions
Medizinisches Zentrum Bonn Friedensplatz
Bonn, NW, DE 

Overview

Christian Kurbacher practices practicing medicine in Bonn, Germany.

Mr. Kurbacher is highly rated in 6 conditions, according to our data. His clinical expertise encompasses HER2 Negative Breast Cancer, Febrile Neutropenia, Breast Cancer, and Agranulocytosis.

He is actively involved in clinical research, co-authoring 34 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

Medizinisches Zentrum Bonn Friedensplatz
Bonn, NW 53111, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Single Arm, Open Label Phase 1b/2 Study of SGN-LIV1A in Combination With Pembrolizumab for First-Line Treatment of Patients With Unresectable Locally-Advanced or Metastatic Triple-Negative Breast Cancer
Single Arm, Open Label Phase 1b/2 Study of SGN-LIV1A in Combination With Pembrolizumab for First-Line Treatment of Patients With Unresectable Locally-Advanced or Metastatic Triple-Negative Breast Cancer
Enrollment Status: Completed
Publish Date: December 12, 2025
Intervention Type: Drug
Study Drugs: ladiratuzumab vedotin, Pembrolizumab
Study Phase: Phase 1/Phase 2
eMonarcHER: A Randomized, Double Blind, Placebo-Controlled Phase 3 Study of Abemaciclib Plus Standard Adjuvant Endocrine Therapy in Participants With High-Risk, Node-Positive, HR+, HER2+ Early Breast Cancer Who Have Completed Adjuvant HER2-Targeted Therapy
eMonarcHER: A Randomized, Double Blind, Placebo-Controlled Phase 3 Study of Abemaciclib Plus Standard Adjuvant Endocrine Therapy in Participants With High-Risk, Node-Positive, HR+, HER2+ Early Breast Cancer Who Have Completed Adjuvant HER2-Targeted Therapy
Enrollment Status: Terminated
Publish Date: July 15, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Standard Adjuvant Endocrine Therapy
Study Phase: Phase 3
Comparison of Quality of Life (QoL) Between Trabectedin/PLD and Standard Platinum-based Therapy in Patients With Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Peritoneal Cancer
Comparison of Quality of Life (QoL) Between Trabectedin/PLD and Standard Platinum-based Therapy in Patients With Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Peritoneal Cancer
Enrollment Status: Terminated
Publish Date: March 20, 2025
Intervention Type: Drug
Study Drug: Trabectidin
Study Phase: Phase 4
View 2 Less Clinical Trials

34 Total Publications

Pelvic Floor Disorders in Women with Breast Cancer and Gynaecological Cancer: Real-World Data from a Prospective Multicentre Cross-Sectional Survey.
Pelvic Floor Disorders in Women with Breast Cancer and Gynaecological Cancer: Real-World Data from a Prospective Multicentre Cross-Sectional Survey.
Journal: Journal of clinical medicine
Published: June 23, 2026

Frequently Asked Questions about Christian M. Kurbacher

Is Christian M. Kurbacher a top-rated expert for HER2 Negative Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Christian M. Kurbacher is classified as an Distinguished expert for HER2 Negative Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Christian M. Kurbacher participate in research or clinical trials?

Yes. Christian M. Kurbacher has published 34 articles and abstracts on conditions like HER2 Negative Breast Cancer. You can view a list of Christian M. Kurbacher's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kurbacher's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile